PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.600
-0.020 (-1.23%)
At close: Mar 11, 2026, 4:00 PM EDT
1.570
-0.030 (-1.88%)
After-hours: Mar 11, 2026, 7:44 PM EDT
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $85.33 million as of March 11, 2026. Its market cap has increased by 15.31% in one year.
Market Cap
85.33M
Enterprise Value
-26.78M
1-Year Change
15.31%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $85.33M, a decrease of -94.71%. That is a compound annual growth rate of -41.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 85.33M | 28.28% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 89.60M |
| Kazia Therapeutics | 89.57M |
| Verrica Pharmaceuticals | 88.26M |
| Pyxis Oncology | 88.10M |
| OKYO Pharma | 85.27M |
| aTyr Pharma | 83.72M |
| MAIA Biotechnology | 82.71M |
| iBio, Inc. | 82.21M |